Prostaglandin D3 – 50 µg

Brand:
Cayman
CAS:
71902-47-1
Storage:
-20
UN-No:
De Minimis - 1231 / 3

Prostaglandin D3 (PGD3) is produced by the metabolism of EPA via the COX pathway.{1144} It is equipotent to PGD2 (Item No. 12010) in decreasing systemic blood pressure in rats and in decreasing intraocular pressure in rabbits.{1139,1138,1225} However, it is 3-5 times more potent than PGD2 in the inhibition of ADP-induced human platelet aggregation.{1139}  

 

Available on backorder

SKU: 12990 - 50 µg Category:

Description

PGD3 is produced by the metabolism of EPA via the COX pathway.{1144} It is equipotent to PGD2 in decreasing systemic blood pressure in rats and in decreasing intraocular pressure in rabbits.{1139,1138,1225} However, it is 3-5 times more potent than PGD2 in the inhibition of ADP-induced human platelet aggregation.{1139}


Formal name: 9α,15S-dihydroxy-11-oxo-prosta-5Z,13E,17Z-trien-1-oic acid

Synonyms:  PGD3

Molecular weight: 350.5

CAS: 71902-47-1

Purity: ≥98%

Formulation: A solution in methyl acetate


Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Cardiovascular System|Blood|Coagulation & Hemostasis||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Neuroscience|Ophthalmology